MoneyWorks4Me

Shamrock Indl. Co - Quaterly Results

19 May 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended March 2023, as compared to corresponding quarter of last year.The Net Loss for the quarter ended March 2023 is Rs. -0.23 millions as compared to Net Loss of Rs. -0.53 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to -0.22% as compared to -0.53% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.97 0.00 0.00 0.97 0.00
PBIDT -0.22 -0.53 -58.49 -1.28 -2.07 -38.16 -1.28 -2.07 -38.16
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.22 -0.53 -58.49 -1.28 -2.07 -38.16 -1.28 -2.07 -38.16
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.22 -0.53 -58.49 -1.28 -2.07 -38.16 -1.28 -2.07 -38.16
TAX 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.23 -0.53 -56.60 -1.29 -2.07 -37.68 -1.29 -2.07 -37.68
Equity 54.28 54.28 0.00 54.28 54.28 0.00 54.28 54.28 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..